In Vitro Evaluation of Drug Solubility and Gamma Irradiation on the Release of Betamethasone under Simulated In Vivo Conditions

In situ—forming biodegradable polymeric systems loaded with betamethasone (BTM) and betamethasone acetate (BTMA) (5, 7, and 10% (w/w)) were prepared using poly(DL-lactide-co-glycolide) (33% (w/w)), ethyl heptanoate (5% (w/w)), and N-methyl-2-pyrrolidone as biodegradable material, additive, and solvent, respectively. The effects of gamma irradiation, drug loading, and solvent removal on release profiles were evaluated. The drug release in phosphate-buffered solution (pH = 7.4, 37°C) was measured using high-performance liquid chromatography. The release profiles of irradiated and nonirradiated formulations based on BTMA showed a three-phase release pattern, whereas the pattern for BTM was biphasic. Gamma irradiation had no significant effect on the BTMA release profiles ( p>0.05). Unexpectedly, irradiation had a significant effect on release behavior of BTM ( p<0.05); also, the rate of BTM release was decreased with an increase in drug loading up to 10%. The amount of BTM that was released in the burst phase decreased by about 1.4 and 1.5 times for 7 and 10% BTM loading, respectively. The duration of BTM release was more than that of BTMA. Changes in hydrophobicity and hydrogen bonding had a strong effect on the release behavior of the two forms of BTM from the in situ—forming systems.

[1]  Y. Bae,et al.  In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof. , 2000, Journal of biomedical materials research.

[2]  Shigeo Kojima,et al.  The effect of γ-irradiation on drug release from poly(lactide) microspheres , 1995 .

[3]  J. Kost,et al.  Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. , 2000, Journal of biomedical materials research.

[4]  R. Herrero-Vanrell,et al.  Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[5]  P. van Hoogevest,et al.  Sustained-release injectables formed in situ and their potential use for veterinary products. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[6]  R. A. Jain, C. T. Rhodes, A. M. Railkar, A. W. Mal,et al.  Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system , 2000 .

[7]  Y. Ogura,et al.  Biodegradable Polymers for Ocular Drug Delivery , 2001, Ophthalmologica.

[8]  H. Moghimi,et al.  FORMULATION OF AN INJECTABLE IMPLANT FOR PEPTIDE DELIVERY AND MECHANISTIC STUDY OF THE EFFECT OF POLYMER MOLECULAR WEIGHT ON ITS RELEASE BEHAVIOR , 2006 .

[9]  P. D. Graham,et al.  Phase inversion dynamics of PLGA solutions related to drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[10]  E. Vasheghani-Farahani,et al.  The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant , 2006 .

[11]  I. Vroman,et al.  Biodegradable Polymers , 2009, Materials.

[12]  Huiming Wang,et al.  Release Behavior and Biological Activity of Recombinant Human Bone Morphogenetic Protein-2 from Porous PLGA Scaffold , 2005 .

[13]  R. Tarantino,et al.  A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) copolymers , 1993 .

[14]  K. Reddy,et al.  Controlled-Release, Pegylation, Liposomal Formulations: New Mechanisms in the Delivery of Injectable Drugs , 2000, The Annals of pharmacotherapy.

[15]  A Hatefi,et al.  Biodegradable injectable in situ forming drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[16]  F. Chiellini Perspectives on:In Vitro Evaluation of Biomedical Polymers , 2006 .

[17]  Chi-Hwa Wang,et al.  Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[18]  R Langer,et al.  In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. , 2000, Biomaterials.

[19]  M Santucci,et al.  Gamma irradiation effects on poly(DL-lactictide-co-glycolide) microspheres. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[20]  R. Ottenbrite,et al.  Perspectives On: Polymeric Drugs and Drug Delivery Systems , 2005 .

[21]  Oladapo Bakare,et al.  Studies on PEGylated and Drug-Loaded PAMAM Dendrimers , 2005 .

[22]  K J Brodbeck,et al.  Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[23]  M. Fresta,et al.  Corticosteroid dermal delivery with skin-lipid liposomes , 1997 .

[24]  R. Bodmeier,et al.  Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[25]  J. Kost,et al.  Delivery of Soluble Tumor Necrosis Factor Receptor from In-Situ Forming PLGA Implants: In-Vivo , 2000, Pharmaceutical Research.

[26]  R. A. Jain,et al.  Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. , 2000, Journal of microencapsulation.

[27]  T. Kissel,et al.  In situ forming parenteral drug delivery systems: an overview. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.